Todd Vienneau

889 total citations
15 papers, 278 citations indexed

About

Todd Vienneau is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Todd Vienneau has authored 15 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 4 papers in Genetics. Recurrent topics in Todd Vienneau's work include Diabetes Management and Research (15 papers), Pancreatic function and diabetes (8 papers) and Diabetes Treatment and Management (7 papers). Todd Vienneau is often cited by papers focused on Diabetes Management and Research (15 papers), Pancreatic function and diabetes (8 papers) and Diabetes Treatment and Management (7 papers). Todd Vienneau collaborates with scholars based in United States and Canada. Todd Vienneau's co-authors include Trang T. Ly, Dessi P. Zaharieva, Michael C. Riddell, Rubin Pooni, Kamuran Turksoy, Lauren M. Huyett, Anders L. Carlson, Bruce W. Bode, Bonnie Dumais and Georgia M. Davis and has published in prestigious journals such as Diabetes Care, Diabetes and Diabetic Medicine.

In The Last Decade

Todd Vienneau

12 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Todd Vienneau United States 7 245 146 117 30 19 15 278
Jodie C. Horsburgh Australia 6 170 0.7× 95 0.7× 67 0.6× 26 0.9× 26 1.4× 9 184
Barbora Paldus Australia 12 289 1.2× 204 1.4× 165 1.4× 26 0.9× 15 0.8× 27 311
Gary Scheiner United States 8 290 1.2× 143 1.0× 130 1.1× 34 1.1× 23 1.2× 23 335
Harald Kojzar Austria 12 478 2.0× 360 2.5× 287 2.5× 94 3.1× 30 1.6× 33 570
Corinne Suppère Canada 11 292 1.2× 195 1.3× 144 1.2× 66 2.2× 45 2.4× 20 370
Andrzej Gawrecki Poland 8 125 0.5× 74 0.5× 78 0.7× 25 0.8× 11 0.6× 25 165
Nirubasini Paramalingam Australia 12 368 1.5× 234 1.6× 189 1.6× 68 2.3× 51 2.7× 26 426
Jill M. Abelseth United States 6 459 1.9× 272 1.9× 199 1.7× 13 0.4× 13 0.7× 7 490
Lars Krinelke Germany 7 364 1.5× 205 1.4× 166 1.4× 17 0.6× 16 0.8× 8 428
Vikash Dadlani United States 6 125 0.5× 92 0.6× 54 0.5× 18 0.6× 8 0.4× 10 151

Countries citing papers authored by Todd Vienneau

Since Specialization
Citations

This map shows the geographic impact of Todd Vienneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd Vienneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd Vienneau more than expected).

Fields of papers citing papers by Todd Vienneau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd Vienneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd Vienneau. The network helps show where Todd Vienneau may publish in the future.

Co-authorship network of co-authors of Todd Vienneau

This figure shows the co-authorship network connecting the top 25 collaborators of Todd Vienneau. A scholar is included among the top collaborators of Todd Vienneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd Vienneau. Todd Vienneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Davis, Georgia M., Anne L. Peters, Bruce W. Bode, et al.. (2024). Glycaemic outcomes in adults with type 2 diabetes over 34 weeks with the Omnipod® 5 Automated Insulin Delivery System. Diabetes Obesity and Metabolism. 27(1). 143–154. 4 indexed citations
2.
Hood, Korey K., William H. Polonsky, Sarah A. MacLeish, et al.. (2023). Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their Caregivers. Pediatric Diabetes. 2023. 1–12. 6 indexed citations
3.
Davis, Georgia M., Anne L. Peters, Bruce W. Bode, et al.. (2023). Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy. Diabetes Care. 46(4). 742–750. 37 indexed citations
4.
Aleppo, Grazia, Daniel J. DeSalvo, Lauren M. Huyett, et al.. (2023). Improvements in Glycemic Outcomes in 4738 Children, Adolescents, and Adults with Type 1 Diabetes Initiating a Tubeless Insulin Management System. Diabetes Therapy. 14(3). 593–610. 6 indexed citations
5.
Polonsky, William H., Korey K. Hood, Carol J. Levy, et al.. (2022). How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 System. Diabetes Research and Clinical Practice. 190. 109998–109998. 37 indexed citations
6.
Carlson, Anders L., et al.. (2021). Improved glycemic control in 3,592 adults with type 2 diabetes mellitus initiating a tubeless insulin management system. Diabetes Research and Clinical Practice. 174. 108735–108735. 12 indexed citations
7.
8.
Aleppo, Grazia, Daniel J. DeSalvo, Lauren M. Huyett, et al.. (2021). 698-P: Glycemic Improvement in 11,273 Adults with Type 1 Diabetes (T1D) Using the Omnipod Insulin Management System over First 90 Days of Use. Diabetes. 70(Supplement_1). 1 indexed citations
9.
Sherr, Jennifer L., Bruce A. Buckingham, Gregory P. Forlenza, et al.. (2020). 1296-P: Omnipod Personalized MPC Algorithm at Target Glucose of 110mg/dl Is Safe in Children Aged 2-12 Years without Increasing Risk of Hypoglycemia. Diabetes. 69(Supplement_1).
10.
Forlenza, Gregory P., Bruce A. Buckingham, Jennifer L. Sherr, et al.. (2020). 978-P: Omnipod Personalized MPC Algorithm at Target Glucose of 110mg/dl Is Safe in Adults and Adolescents without Increasing Risk of Hypoglycemia. Diabetes. 69(Supplement_1).
11.
12.
Brown, Ruth E., Todd Vienneau, & Ronnie Aronson. (2020). Canadian Real‐World Outcomes of Omnipod Initiation in People with Type 1 Diabetes (COPPER study): Evidence from the LMC Diabetes Registry. Diabetic Medicine. 38(6). e14420–e14420. 6 indexed citations
13.
Zaharieva, Dessi P., Kamuran Turksoy, Rubin Pooni, et al.. (2019). Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes. Diabetes Technology & Therapeutics. 21(6). 313–321. 90 indexed citations
14.
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jodie C. Horsburgh Breakdown of academic impact, for papers by Barbora Paldus Breakdown of academic impact, for papers by Gary Scheiner Breakdown of academic impact, for papers by Harald Kojzar Breakdown of academic impact, for papers by Corinne Suppère Breakdown of academic impact, for papers by Andrzej Gawrecki Breakdown of academic impact, for papers by Nirubasini Paramalingam Breakdown of academic impact, for papers by Jill M. Abelseth Breakdown of academic impact, for papers by Lars Krinelke Breakdown of academic impact, for papers by Vikash Dadlani
Rankless by CCL
2026